RT @JanssenUS: We’ve partnered with #lungcancer fighters, survivors, care partners and advocates like @rhondameckstro1 and @bjork5 to creat…
Lung cancer is the leading cause of cancer deaths globally, and often detected too late, with more than half of cases metastasizing by the time they are first diagnosed, but there is hope. #LungCancerAwarenessMonth (1/2) https://t.co/yVFQwuC4cH
For 125 years, #JNJ has supported people who are at the heart of delivering care. Check out this special segment with the @TODAYshow showcasing @trap_medicine’s mission to eliminate health disparities among communities of color. https://t.co/Vw4OGaoi2w
More and more, many previously effective medications are no longer able to fight off the germs that are making us sick, leading to millions of deaths each year. For World Antimicrobial Awareness Week, learn what Johnson & Johnson is doing to combat this health threat around the world.
Johnson & Johnson earned the #2 spot on the Access to Medicine Index, an important measurement of the company's longstanding commitment to make lifesaving medicine available and accessible to those who need it most.
Rates of this blood cancer have jumped more than 125% worldwide since the 1990s. But there's reason to have hope: Today, life expectancy has at least doubled in some cases. That's thanks to increased research, new learnings and innovative advances—and Johnson & Johnson is at the forefront of this crucial work.